TCL Archive Letter to the Editors: BSA P01 Review Vote Was Advisory, NCI Official Says December 5, 1997
TCL Archive Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer November 28, 2014
TCL Archive FDA to Move Away From Central Radiology To Investigator Review In PFS Endpoint Trials July 27, 2012
TCL Archive Long-term Follow-up Shows ADH and ALH Tissue Abnormalities Can Carry Similar Risk January 31, 2014
